Formulation and Evaluation of Sustained Release Floating Tablets of an Antihypertensive Diltiazem

DOI:

https://doi.org/10.37285/ijpsn.2017.10.5.5

Authors

  • Gururaj S Kulkarni
  • Prabhansh P Chaudhary
  • Shivakumar Swamy

Abstract

The aim of the present study was to develop and evaluate sustained release floating tablets of Diltiazem hydro-chloride, an antihypertensive agent. The sustained release floating tablets were prepared by direct compression method and formulated using different polymer combinations, formulations such as F1 to F9. Natural polymer Sodium alginate and synthetic polymer HPMC K4M were used. Developed formulations were evaluated for the pre compression parameters i.e., drug- excipients compatibility by FTIR, bulk density, compressibility, and angle of repose etc. Post compression parameters i.e. weight variation; full factorial design was applied to optimize the developed formulation. SA and HPMC K4M were selected as independent variable at three different concentrations. The in-vitro drug release study revealed that formulation F8 combination of both synthetic (HPMC) and natural polymers (sodium alginate) was the most successful formulation of the study, all tablets but

one exhibited gradual and near complete sustained release for diltiazem HCl (90-100%) that extended the drug release up to 8 hours, with satisfactory drug release in the initial hours, and the total release pattern was close to the theoretical release profile.  Model equations of zero and first order, Higuchi, Hixson-Crowell and Peppas, intended to elucidate the drug release mechanism, and were fitted to the release data. Mathematical modelling of in-vitro dissolution data indicated the best-fit release kinetics was achieved with Higuchi model with r2 vales of 0.994 in its semi log plot. The ‘n’ value in Higuchi model was >0.89 which indicated, Super Case-II transport of drug from polymer sustained, i.e., diffusion with relaxation of polymeric chain. In conclusion, the results indicated that the prepared sustained-release tablets of Diltiazem hydrochloride could perform therapeutically better than conventional tablets with improved efficacy and better patient compliance.   

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Diltiazem, floating tablet, Sustained-release, Sodium alginate;, HPMC, Drug release

Downloads

Published

2017-09-30

How to Cite

1.
Kulkarni GS, Chaudhary PP, Swamy S. Formulation and Evaluation of Sustained Release Floating Tablets of an Antihypertensive Diltiazem. Scopus Indexed [Internet]. 2017 Sep. 30 [cited 2024 Dec. 11];10(5):3844-52. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/863

Issue

Section

Research Articles

References

Asija R, Asija S, Bhatt S, Sharma D, Shah A, and Sharma P (2015). Formulation and evaluation of floating tablet of Valsartan. ARPB 5(1): 834-838.
Charyulu RN, et al (2011). Development of gastroretentive floating matrix tablets of Diltiazem hydrochloride. Nitte University Journal of Health Science 1(3): 38-45.
Dubey V, and Arora V (2012). Formulation and evaluation of floating tablet of Amlodipine besilate with natural polymer chitosan. JPSI 1(4): 13-18.
Kumar R, Patil MB, Patil SR, and Paschapur MS (2009). Formulation and evaluation of effervescent floating tablet of Famotidine. Int J Pharm Tech Res 1(3): 754-63.
Laxmi PK, et al (2013). Formulation and In Vitro Evaluation of Gastro Retentive Delivery of Diltiazem Hydrochloride Using Natural Polymers. International Journal of Pharma Science 3(1): 129-35.
Masih D (2012). Development and evaluation of floating dosage form containing Atenolol. IJPI 2(5): 38-48.
Patel AN, Patel FM, and Rathor KS (2011). Formulation and characterization of floating of Diltiazem hydrochloride. JPBMS 9(11): 1-6.
Patel H and Jaimini M (2013). Formulation development and of Diltiazem Hydrochloride gastro retentive floating tablets. Journal of drug delivery and therapeutics 3(30): 48-55.
Prathyusha S, Kumar MY, Lavanaya D and Kumar MK (2014). Preparation and evaluation of gastro retentive floating tablets of Quetiapine fumarate. Mintage Journal pharmaceutical and Medical Sciences 3(2): 10-14.
Pundir S, Badola A, and Sharma D (2013). Sustained release matrix technology and recent advance matrix drug delivery system: A review. Int J Drug Res Tech. 3(1): 12-20.
Sagar S, Srividya L, and Nanjawadw BK (2015). Formulation and evaluation of gastroretentive floating tablets of Quetiapine Fumarate. IAJPS 2(5): 912-25.
Sahu H, Jain V, Upmanyu N, Mishra SS, and Raghuwanshi N (2011). Formulation and evaluluation of effervescent floating tablet of levofloxacin. Der Pharmacia Lettre 3(6): 272-279.
Singh HP, Kaur A, and Kaur I (2014). Formulation and evaluations of effervescent tablet of Famotidine with natural polymer Chitosan. Asian Pac J Health Sci 1(4): 517-523.
Suresh G, Pavan P, Bikshapathi DRN, and Rao YM (2013), Formulation and evaluation of floating gastroretentive drug delivery system of Diltiazem hydrochloride. Int J Pharm Bio Sci 4(2): 538-48.
Tiwari AK, and Rabadia N (2012). Formulation and optimization of effervescent floating tablet of Diltiazem hydrochloride using response surface methodology. Journal of Pharmacy Research 5(7): 3506-14.
Tripathi KD (2013). Essentials of medical pharmacology. 7th ed. Jaypee Brothers Medical Publishers 558-74.
Wilson KRW, and Waugh, A (2002). Anatomy and physiology in health and illness.9th ed. John Willey and sons, New York 78-90.